Suppressive effects of nimesulide, a selective inhibitor of cyclooxygenase-2, on azoxymethane-induced colon carcinogenesis in mice

Carcinogenesis

Volumn 19, Issue 11, 1998, Pages 1939-1942

  Fukutake, Masato ^a   Nakatsugi, Seiichi ^a,b   Isoi, Takashi ^a,b   Takahashi, Mami ^a   Ohta, Toshihisa ^a   Mamiya, Souichi ^a   Taniguchi, Yasuaki ^c   Sato, Hidetaka ^d   Fukuda, Kazunori ^a   Sugimura, Takashi ^a   Wakabayashi, Keiji ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b SAWAI PHARMACEUTICAL CO LTD   (Japan)

^c HISAMITSU PHARMACEUTICAL CO INC   (Japan)

^d JAPAN FOOD RESEARCH LABORATORIES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZOXYMETHANE; CARCINOGEN; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; NIMESULIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON CARCINOGENESIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031721083     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/19.11.1939     Document Type: Article

References (32)

1. Broder, S. (1993) Perspectives on cancer in Japan and the United States. Jpn. J. Cancer Res., 84, 821-830.
2. Thun, M.J., Namboodiri, M.M. and Heath, C.W.Jr (1991) Aspirin use and reduced risk of fatal colon cancer. N. Engl. J. Med., 325, 1593-1596.
3. Reddy, B.S., Maruyama, H. and Kelloff, G. (1987) Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal anti-inflammatory drug, during different stages of rat colon tumor development. Cancer Res., 47, 5340-5346.
4. Reddy, B.S., Rao, C.V., Rivenson, A. and Kelloff, G. (1993) Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats. Carcinogenesis, 14, 1493-1497.
5. Reddy, B.S., Tokumo, K., Kulkarni, N., Aligia, C. and Kelloff, G. (1992) Inhibition of colon carcinogenesis by prostaglandin synthesis inhibitors and related compounds. Carcinogenesis, 13, 1019-1023.
6. Rao, C.V., Rivenson, A., Simi, B., Zang, E., Kelloff, G., Steele, V. and Reddy, B.S. (1995) Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent. Cancer Res., 55, 1464-1472.
7. Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam. Cancer Res., 56, 710-714.
8. Boolbol, S.K., Dannenberg, A.J., Chadburn, A. et al. (1996) Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res., 56, 2556-2560.
9. Labyle, D., Fischer, D., Vielh, P., Drouhin, F., Pariente, A., Bories, C., Duhamel, O., Trousset, M. and Attali, P. (1991) Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology, 101, 635-639.
10. Giardiello, F.M., Hamilton, S.R., Krush, A.J., Piantadoshi, S., Hylind, L.M., Celano, P., Booker, S.V., Robinson, C.R. and Offerhaus, G.J. (1993) Treatment of colonie and rectal adenomas with sulindac in familial adenomatous polyposis. N. Engl. J. Med., 328, 1313-1316.
11. Xie, W.L., Chipman, J.G., Robertson, D.L., Erikson, R.L. and Simmons, D.L. (1991) Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc. Natl Acad. Sci. USA, 88, 2692-2696.
12. Herschman, H.R. (1996) Prostaglandin synthase 2. Biochim. Biophys. Acta, 1299, 125-140.
13. DuBois, R.N., Radhika, A., Reddy, B.S. and Entingh, A.J. (1996) Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology, 110, 1259-1262.
14. Eberhart, C.E., Coffey, R.J., Radhika, A., Giardiello, F.M., Ferrenbach, S. and DuBois, R.N. (1994) Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology, 107, 1183-1188.
15. Kargman, S.L., O'Neill, G.P. Vickers, P.J., Evans, J.F, Mancini, J.A. and Jothy, S. (1995) Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res., 55, 2556-2559.
16. Sano, H., Kawahito, Y., Wilder, R.L., Hashimoto, A, Mukai, S., Asai, K., Kimura, S., Kato, H., Kondo, M. and Hla, T. (1995) Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res., 55, 3785-3789.
17. Vane, J (1994) Towards a better aspirin. Nature, 367, 215-216.
18. Taniguchi, Y., Ikesue, A., Yokoyama, K., Noda, K., Debuchi, H., Nakamura, T., Toda, A. and Shimeno, H. (1995) Selective inhibition by nimesulide, a novel non-steroidal anti-inflammatory drug, with prostaglandin endoperoxide synthase-2 activity in-vitro. Pharm. Sci., 1, 173-175.
19. Swingle, K.F. and Moore, G.G.I. (1984) Preclinical pharmacological studies with nimesulide. Drugs Exp. Clin. Res., 10, 587-597.
20. Boettcher, I., Schweizer, A., Glatt, M. and Werner, H. (1987) A sulphonamido-indanone derivative CGP 28237 (ZK 34228), a novel nonsteroidal anti-inflammatory agent without gastro-intestinal ulcerogenicity in rats. Drugs Evp. Clin. Res., 13, 237-245.
21. Cipollini, F., Mecozzi, V. and Altilia, F. (1989) Endoscopic assessment of the effects of nimesulide on the gastric mucosa: comparison with indomethacin. Curr. Ther. Res., 45, 1042-1048.
22. Nakatsugi, S., Terada, N., Yoshimura, T., Horie, Y. and Furukawa, M. (1996) Effects of nimesulide, a preferential cyclooxygenase-2 inhibitor, on carrageenan-induced pleurisy and stress-induced gastric lesions in rats. Prostaglandins Leukot. Essent. Fatty Acids, 55, 395-402.
23. Takahashi, M., Fukutake, M., Yokota, S., Ishida, K., Wakabayashi, K. and Sugimura, T. (1996) Suppression of azoxymethane-induced aberrant crypt foci in rat colon by nimesulide, a selective inhibitor of cyclooxygenase 2. J. Cancer Res. Clin. Oncol. 166, 219-222.
24. Nakatsugi, S., Fukutake, M., Takahashi, M., Fukuda, K., Isoi, T., Taniguchi, Y., Sugimura, T. and Wakabayashi, K. (1997) Suppression of intestinal polyp development by nimesulide, a selective cyclooxygenase-2 inhibitor, in Min mice. Jpn. J. Cancer Res., 88, 1117-1120.
25. Takahashi, M., Fukutake, M., Isoi, T., Fukuda, K., Sato, H., Yazawa, K., Sugimura, T. and Wakabayashi, K. (1997) Suppression of azoxymethane-induced rat colon carcinoma development by a fish oil component, docosahexaenoic acid (DHA). Carcinogenesis, 18, 1337-1342.
26. Tsujii, M. and DuBois, R.N. (1995) Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell, 83, 493-501.
27. Sheng, G.G., Shao, J., Sheng, H., Hooton, E.B., Isakson, P.C. Morrow, J.D., Coffey, R.J. Jr. DuBois, R.N. and Beauchamp, R.D. (1997) A selective cyclooxygenase 2 inhibitor suppresses the growth of H-ras-transformed rat intestinal epithelial cells. Gastroenterology, 113, 1883-1891.
28. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell, 87, 803-809.
29. Kawamori, T., Rao, C.V., Seibert, K. and Reddy, B.S. (1998) Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res., 58, 409-412.
30. Masferrer, J.L., Zweifel, B.S., Manning, P.T., Hauser, S.D., Leahy, K.M., Smith, W.G., Isakson, P.C. and Seibert, K. (1994) Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc. Natl Acad. Sci. USA, 91, 3228-3232.
31. Reits, D.B., Li, J.J., Norton, M.B., Reinhard, E.J. et al. (1994) Selective cyclooxygenase inhibitors: novel 1,2-diarylcyclopentenes are potent and orally active COX-2 inhibitors. J. Med. Chem., 37, 3878-3881.
32. Futaki, N., Takahashi, S., Yokoyama, M., Arai, I., Higuchi, S. and Otomo, S. (1994) NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins, 47, 55-59.